Literature DB >> 33770151

Prevalence of pfk13 and pfmdr1 polymorphisms in Bounkiling, Southern Senegal.

Ambroise Ahouidi1,2, Rafael Oliveira3, Lis Lobo3, Cyrille Diedhiou2, Souleymane Mboup2, Fatima Nogueira3.   

Abstract

BACKGROUND: Delayed Plasmodium falciparum parasite clearance has been associated with Single Nucleotide Polymorphisms (SNPs) in the kelch protein propeller domain (coded by pfk13 gene). SNPs in the Plasmodium falciparum multidrug resistance gene 1 (pfmdr1) are associated with multi-drug resistance including the combination artemether-lumefantrine. To our knowledge, this is the first work providing information on the prevalence of k13-propeller and pfmdr1 mutations from Sédhiou, a region in the south of Senegal.
METHODS: 147 dried blood spots on filter papers were collected from symptomatic patients attending a hospital located in Bounkiling City, Sédhiou Region, Southern Senegal. All samples were collected between 2015-2017 during the malaria transmission season. Specific regions of the gene pfk13 and pfmdr1 were analyzed using PCR amplification and Sanger sequencing.
RESULTS: The majority of parasites (92.9%) harboured the pfk13 wild type sequence and 6 samples harboured synonymous changes. Regarding pfmdr1, wild-type alleles represented the majority except at codon 184. Overall, prevalence of 86Y was 11.9%, 184F was 56.3% and 1246Y was 1.5%. The mutant allele 184F decreased from 73.7% in 2015 to 40.7% in 2017. The prevalence of haplotype NFD decreased from 71.4% in 2015 to 20.8% in 2017.
CONCLUSIONS: This study provides the first description of pfk13 and pfmdr1 genes variations in Bounkiling, a city in the Sédhiou Region of Senegal, contributing to closing the gap of information on anti-malaria drug resistance molecular markers in southern Senegal.

Entities:  

Year:  2021        PMID: 33770151      PMCID: PMC7996989          DOI: 10.1371/journal.pone.0249357

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  57 in total

1.  Modulation of in vitro antimalarial responses by polymorphisms in Plasmodium falciparum ABC transporters (pfmdr1 and pfmdr5).

Authors:  Mathieu Gendrot; Mamadou Wague Gueye; Francis Tsombeng Foguim; Marylin Madamet; Khalifa Ababacar Wade; Mame Bou Kounta; Mansour Fall; Silman Diawara; Nicolas Benoit; Gora Lo; Raymond Bercion; Rémy Amalvict; Joel Mosnier; Bécaye Fall; Sébastien Briolant; Bakary Diatta; Bruno Pradines
Journal:  Acta Trop       Date:  2019-05-17       Impact factor: 3.112

2.  In vivo selection of Plasmodium falciparum Pfcrt and Pfmdr1 variants by artemether-lumefantrine and dihydroartemisinin-piperaquine in Burkina Faso.

Authors:  Vito Baraka; Halidou Tinto; Innocent Valea; Robert Fitzhenry; Christopher Delgado-Ratto; Martin K Mbonye; Chantal Van Overmeir; Anna Rosanas-Urgell; Jean-Pierre Van Geertruyden; Umberto D'Alessandro; Annette Erhart
Journal:  Antimicrob Agents Chemother       Date:  2014-11-17       Impact factor: 5.191

3.  Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number.

Authors:  Ric N Price; Anne-Catrin Uhlemann; Alan Brockman; Rose McGready; Elizabeth Ashley; Lucy Phaipun; Rina Patel; Kenneth Laing; Sornchai Looareesuwan; Nicholas J White; François Nosten; Sanjeev Krishna
Journal:  Lancet       Date:  2004 Jul 31-Aug 6       Impact factor: 79.321

4.  A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms.

Authors:  Didier Ménard; Nimol Khim; Johann Beghain; Ayola A Adegnika; Mohammad Shafiul-Alam; Olukemi Amodu; Ghulam Rahim-Awab; Céline Barnadas; Antoine Berry; Yap Boum; Maria D Bustos; Jun Cao; Jun-Hu Chen; Louis Collet; Liwang Cui; Garib-Das Thakur; Alioune Dieye; Djibrine Djallé; Monique A Dorkenoo; Carole E Eboumbou-Moukoko; Fe-Esperanza-Caridad J Espino; Thierry Fandeur; Maria-Fatima Ferreira-da-Cruz; Abebe A Fola; Hans-Peter Fuehrer; Abdillahi M Hassan; Socrates Herrera; Bouasy Hongvanthong; Sandrine Houzé; Maman L Ibrahim; Mohammad Jahirul-Karim; Lubin Jiang; Shigeyuki Kano; Wasif Ali-Khan; Maniphone Khanthavong; Peter G Kremsner; Marcus Lacerda; Rithea Leang; Mindy Leelawong; Mei Li; Khin Lin; Jean-Baptiste Mazarati; Sandie Ménard; Isabelle Morlais; Hypolite Muhindo-Mavoko; Lise Musset; Kesara Na-Bangchang; Michael Nambozi; Karamoko Niaré; Harald Noedl; Jean-Bosco Ouédraogo; Dylan R Pillai; Bruno Pradines; Bui Quang-Phuc; Michael Ramharter; Milijaona Randrianarivelojosia; Jetsumon Sattabongkot; Abdiqani Sheikh-Omar; Kigbafori D Silué; Sodiomon B Sirima; Colin Sutherland; Din Syafruddin; Rachida Tahar; Lin-Hua Tang; Offianan A Touré; Patrick Tshibangu-wa-Tshibangu; Inès Vigan-Womas; Marian Warsame; Lyndes Wini; Sedigheh Zakeri; Saorin Kim; Rotha Eam; Laura Berne; Chanra Khean; Sophy Chy; Malen Ken; Kaknika Loch; Lydie Canier; Valentine Duru; Eric Legrand; Jean-Christophe Barale; Barbara Stokes; Judith Straimer; Benoit Witkowski; David A Fidock; Christophe Rogier; Pascal Ringwald; Frederic Ariey; Odile Mercereau-Puijalon
Journal:  N Engl J Med       Date:  2016-06-23       Impact factor: 91.245

5.  K13-propeller polymorphisms in Plasmodium falciparum parasites from sub-Saharan Africa.

Authors:  Edwin Kamau; Susana Campino; Lucas Amenga-Etego; Eleanor Drury; Deus Ishengoma; Kimberly Johnson; Dieudonne Mumba; Mihir Kekre; William Yavo; Daniel Mead; Marielle Bouyou-Akotet; Tobias Apinjoh; Lemu Golassa; Milijaona Randrianarivelojosia; Ben Andagalu; Oumou Maiga-Ascofare; Alfred Amambua-Ngwa; Paulina Tindana; Anita Ghansah; Bronwyn MacInnis; Dominic Kwiatkowski; Abdoulaye A Djimde
Journal:  J Infect Dis       Date:  2014-11-02       Impact factor: 5.226

6.  Artemether resistance in vitro is linked to mutations in PfATP6 that also interact with mutations in PfMDR1 in travellers returning with Plasmodium falciparum infections.

Authors:  Dylan R Pillai; Rachel Lau; Krishna Khairnar; Rosalba Lepore; Allegra Via; Henry M Staines; Sanjeev Krishna
Journal:  Malar J       Date:  2012-04-27       Impact factor: 2.979

7.  Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine Exert Inverse Selective Pressure on Plasmodium Falciparum Drug Sensitivity-Associated Haplotypes in Uganda.

Authors:  Aimee R Taylor; Jennifer A Flegg; Chris C Holmes; Philippe J Guérin; Carol H Sibley; Melissa D Conrad; Grant Dorsey; Philip J Rosenthal
Journal:  Open Forum Infect Dis       Date:  2016-10-25       Impact factor: 3.835

8.  High throughput resistance profiling of Plasmodium falciparum infections based on custom dual indexing and Illumina next generation sequencing-technology.

Authors:  Sidsel Nag; Marlene D Dalgaard; Poul-Erik Kofoed; Johan Ursing; Marina Crespo; Lee O'Brien Andersen; Frank Møller Aarestrup; Ole Lund; Michael Alifrangis
Journal:  Sci Rep       Date:  2017-05-25       Impact factor: 4.379

9.  Polymorphism in dhfr/dhps genes, parasite density and ex vivo response to pyrimethamine in Plasmodium falciparum malaria parasites in Thies, Senegal.

Authors:  Daouda Ndiaye; Baba Dieye; Yaye D Ndiaye; Daria Van Tyne; Rachel Daniels; Amy K Bei; Aminata Mbaye; Clarissa Valim; Amanda Lukens; Souleymane Mboup; Omar Ndir; Dyann F Wirth; Sarah Volkman
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2013-08-12       Impact factor: 4.077

10.  Sustained Ex Vivo Susceptibility of Plasmodium falciparum to Artemisinin Derivatives but Increasing Tolerance to Artemisinin Combination Therapy Partner Quinolines in The Gambia.

Authors:  Alfred Amambua-Ngwa; Joseph Okebe; Haddijatou Mbye; Sukai Ceesay; Fatima El-Fatouri; Fatou Joof; Haddy Nyang; Ramatoulie Janha; Muna Affara; Abdullahi Ahmad; Olimatou Kolly; Davis Nwakanma; Umberto D'Alessandro
Journal:  Antimicrob Agents Chemother       Date:  2017-11-22       Impact factor: 5.191

View more
  3 in total

1.  Artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Liberia: in vivo efficacy and frequency of molecular markers.

Authors:  Victor S Koko; Marian Warsame; Benjamin Vonhm; Moses K Jeuronlon; Didier Menard; Laurence Ma; Fahn Taweh; Lekilay Tehmeh; Paye Nyansaiye; Oliver J Pratt; Sei Parwon; Patrick Kamara; Magnus Asinya; Aaron Kollie; Pascal Ringwald
Journal:  Malar J       Date:  2022-04-27       Impact factor: 3.469

Review 2.  Prevalence of potential mediators of artemisinin resistance in African isolates of Plasmodium falciparum.

Authors:  Afolabi Owoloye; Michael Olufemi; Emmanuel T Idowu; Kolapo M Oyebola
Journal:  Malar J       Date:  2021-12-02       Impact factor: 3.469

3.  Xeno-monitoring of molecular drivers of artemisinin and partner drug resistance in P. falciparum populations in malaria vectors across Cameroon.

Authors:  Francis N Nkemngo; Leon M J Mugenzi; Magellan Tchouakui; Daniel Nguiffo-Nguete; Murielle J Wondji; Bertrand Mbakam; Micareme Tchoupo; Cyrille Ndo; Samuel Wanji; Charles S Wondji
Journal:  Gene       Date:  2022-02-17       Impact factor: 3.688

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.